[1]CurrentPatentAssignee:ABBOTTLABORATORIESINC-WO2010/54024,2010,A2Locationinpatent:Page/Pagecolumn126-127
[2]CurrentPatentAssignee:BAYERAG-EP1054881,2008,B1Locationinpatent:Page/Pagecolumn45
[3]CurrentPatentAssignee:BAYERAG-US6051586,2000,A
[4]CurrentPatentAssignee:NAVITORPHARM;NAVITORPHARMACEUTICALS-US2017/114080,2017,A1Locationinpatent:Paragraph0597
[5]CurrentPatentAssignee:ABBVIEINC-WO2008/130953,2008,A2Locationinpatent:Page/Pagecolumn111
[6]CurrentPatentAssignee:NAVITORPHARMACEUTICALS;NAVITORPHARM-WO2018/200625,2018,A1Locationinpatent:Paragraph00513;00514;00515
Title: 2beta-(N-substituted piperazino)-5alpha-androstane-3alpha,17beta-diols: parallel solid-phase synthesis and antiproliferative activity on human leukemia HL-60 cells.
Journal: Journal of combinatorial chemistry 20070101